This site is intended for healthcare professionals only
LoginRegister
Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI StatusGST Department Launches Search, Inspection at Cipla's Maharashtra Facilities
Shukra Pharma to Invest Rs 600 Cr in Greater Noida Medical Device Park, Enters Surgical Robotics, Cancer Therapy TechShukra Pharma to Invest Rs 600 Cr in Greater Noida Medical Device Park, Enters Surgical Robotics,...
From Allergy Pills to PPIs: MPs Flag Massive Overpricing of Medicines, Seek Pricing ReformsFrom Allergy Pills to PPIs: MPs Flag Massive Overpricing of Medicines, Seek Pricing Reforms
USFDA Approves Alembics Dapagliflozin Tablets, Grants 180-Day ExclusivityAlembic Pharma Gets USFDA Final Approval for Parkinson's Drug Stalevo Generic
Zydus Lifesciences Slapped Rs 1.42 Crore Tax Demand, Plans to Challenge OrderUSFDA Grants Orphan Drug Status to Zydus' Desidustat for Sickle Cell Disease
Gland Pharma Faces Rs 6.29 Cr GST Demand, Plans to Challenge Tax OrderGland Pharma Gets USFDA Nod for Zoledronic Acid Injection for Cancer-Related Bone Disorders
Sun Pharma Seals Rs 97,500 Crore Organon Acquisition DealSun Pharma to Invest Rs 500 Cr in Assam Manufacturing Plant, 500+ Jobs Expected
Mankind Pharma Gets Relief as CGST Appellate Authority Drops Rs 1.02 Cr PenaltyMankind Pharma Reports 11.5% Revenue Growth in Q3 FY26
States Cannot Prescribe Additional Eligibility for Drug Inspector Posts Beyond Central Law: SCStates Cannot Prescribe Additional Eligibility for Drug Inspector Posts Beyond Central Law: SC
Pune FDA Crackdown: 102 Chemist Licences Cancelled, 286 Suspended Over Drug Law ViolationsNavi Mumbai Airport May Join Cochin, Thiruvananthapuram as Drug Import Gateway
Sun Pharma Makes Cricket Debut as RCB Principal Sponsor from 2026Sun Pharma Makes Cricket Debut as RCB Principal Sponsor from 2026
Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026
X